DNA vaccines: a rational design against parasitic diseases
- PMID: 20109028
- DOI: 10.1586/erv.09.158
DNA vaccines: a rational design against parasitic diseases
Abstract
Parasitic diseases are one of the most devastating causes of morbidity and mortality worldwide. Although immunization against these infections would be an ideal solution, the development of effective vaccines has been hampered by specific challenges posed by parasitic pathogens. Plasmid-based DNA vaccines may prove to be promising immunization tools in this area because vectors can be designed to integrate several antigens from different stages of the parasite life cycle or different subspecies; vaccines, formulations and immunization protocols can be tuned to match the immune response that offers protective immunity; and DNA vaccination is an affordable platform for developing countries. Partial and full protective immunity have been reported following DNA vaccination against the most significant parasitic diseases in the world.
Similar articles
-
[The new generations of vaccines against parasites].Wiad Parazytol. 2000;46(1):21-7. Wiad Parazytol. 2000. PMID: 16886350 Review. Polish.
-
DNA vaccines against tropical parasitic diseases.Expert Rev Vaccines. 2005 Aug;4(4):575-89. doi: 10.1586/14760584.4.4.575. Expert Rev Vaccines. 2005. PMID: 16117713 Review.
-
Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.Vaccine. 2008 Aug 18;26(35):4541-8. doi: 10.1016/j.vaccine.2008.06.030. Epub 2008 Jun 30. Vaccine. 2008. PMID: 18590785
-
DNA vaccines and their application against parasites--promise, limitations and potential solutions.Biotechnol Annu Rev. 2004;10:189-236. doi: 10.1016/S1387-2656(04)10007-0. Biotechnol Annu Rev. 2004. PMID: 15504707 Review.
-
Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.Vaccine. 2007 Nov 14;25(46):7962-71. doi: 10.1016/j.vaccine.2007.08.023. Epub 2007 Aug 30. Vaccine. 2007. PMID: 17942199
Cited by
-
Construction and In vitro Expression Analyses of a DNA Plasmid Encoding Dense Granule GRA5 Antigen of Toxoplasma gondii.Avicenna J Med Biotechnol. 2011 Jul;3(3):135-41. Avicenna J Med Biotechnol. 2011. PMID: 23407179 Free PMC article.
-
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.Gene Ther. 2015 Aug;22(8):628-35. doi: 10.1038/gt.2015.35. Epub 2015 Apr 30. Gene Ther. 2015. PMID: 25871827 Free PMC article.
-
Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection.BMC Infect Dis. 2014 May 16;14:263. doi: 10.1186/1471-2334-14-263. BMC Infect Dis. 2014. PMID: 24886395 Free PMC article.
-
Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.J Virol. 2012 Sep;86(18):9782-93. doi: 10.1128/JVI.00694-12. Epub 2012 Jul 3. J Virol. 2012. PMID: 22761378 Free PMC article.
-
Micro- and nanoparticulates for DNA vaccine delivery.Exp Biol Med (Maywood). 2016 May;241(9):919-29. doi: 10.1177/1535370216643771. Epub 2016 Apr 4. Exp Biol Med (Maywood). 2016. PMID: 27048557 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical